Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 24382161)

1.

Uroplakin II outperforms uroplakin III in diagnostically challenging settings.

Smith SC, Mohanty SK, Kunju LP, Chang E, Chung F, Carvalho JC, Paner GP, Hansel DE, Luthringer DJ, de Peralta-Ventrurina MN, Amin MB.

Histopathology. 2014 Jul;65(1):132-8. doi: 10.1111/his.12360. Epub 2014 Feb 25.

PMID:
24382161
2.

Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants.

Li W, Liang Y, Deavers MT, Kamat AM, Matin SF, Dinney CP, Czerniak B, Guo CC.

Am J Clin Pathol. 2014 Dec;142(6):864-71. doi: 10.1309/AJCP1J0JPJBPSUXF.

PMID:
25389341
3.

Utility of uroplakin II expression as a marker of urothelial carcinoma.

Tian W, Guner G, Miyamoto H, Cimino-Mathews A, Gonzalez-Roibon N, Argani P, Li X, Sharma R, Subhawong AP, Rezaei K, Bivalacqua TJ, Epstein JI, Bishop JA, Netto GJ.

Hum Pathol. 2015 Jan;46(1):58-64. doi: 10.1016/j.humpath.2014.09.007. Epub 2014 Oct 2.

PMID:
25449628
4.

A newly developed uroplakin II antibody with increased sensitivity in urothelial carcinoma of the bladder.

Hoang LL, Tacha DE, Qi W, Yu C, Bremer RE, Chu J, Haas TS, Cheng L.

Arch Pathol Lab Med. 2014 Jul;138(7):943-9. doi: 10.5858/arpa.2013-0221-OA.

PMID:
24978921
5.

Utility of GATA3 immunohistochemistry in differentiating urothelial carcinoma from prostate adenocarcinoma and squamous cell carcinomas of the uterine cervix, anus, and lung.

Chang A, Amin A, Gabrielson E, Illei P, Roden RB, Sharma R, Epstein JI.

Am J Surg Pathol. 2012 Oct;36(10):1472-6. doi: 10.1097/PAS.0b013e318260cde7.

6.
7.

Is GATA3 expression maintained in regional metastases?: a study of paired primary and metastatic urothelial carcinomas.

Zhao L, Antic T, Witten D, Paner GP, Taxy JB, Husain A, Gwin K, Mirza MK, Lingen MW, Tretiakova MS.

Am J Surg Pathol. 2013 Dec;37(12):1876-81. doi: 10.1097/PAS.0b013e31829e2525.

PMID:
24121175
8.

Selective immunohistochemical markers to distinguish between metastatic high-grade urothelial carcinoma and primary poorly differentiated invasive squamous cell carcinoma of the lung.

Gruver AM, Amin MB, Luthringer DJ, Westfall D, Arora K, Farver CF, Osunkoya AO, McKenney JK, Hansel DE.

Arch Pathol Lab Med. 2012 Nov;136(11):1339-46. doi: 10.5858/arpa.2011-0575-OA.

PMID:
23106579
9.

Different immunohistochemical and ultrastructural phenotypes of squamous differentiation in bladder cancer.

Gaisa NT, Braunschweig T, Reimer N, Bornemann J, Eltze E, Siegert S, Toma M, Villa L, Hartmann A, Knuechel R.

Virchows Arch. 2011 Mar;458(3):301-12. doi: 10.1007/s00428-010-1017-2. Epub 2010 Dec 7.

PMID:
21136076
10.
11.

Urothelial umbrella cells of human ureter are heterogeneous with respect to their uroplakin composition: different degrees of urothelial maturity in ureter and bladder?

Riedel I, Liang FX, Deng FM, Tu L, Kreibich G, Wu XR, Sun TT, Hergt M, Moll R.

Eur J Cell Biol. 2005 Mar;84(2-3):393-405.

PMID:
15819416
12.

Immunohistochemistry in diagnostic surgical pathology of the prostate.

Hameed O, Humphrey PA.

Semin Diagn Pathol. 2005 Feb;22(1):88-104. Review.

PMID:
16512601
14.

Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma.

Mhawech P, Uchida T, Pelte MF.

Hum Pathol. 2002 Nov;33(11):1136-40.

PMID:
12454820
15.
16.
17.

Significance of uroplakin III expression in recurrence of solitary muscle non-invasive bladder cancer.

Tadin T, Krpina K, Štifter S, Babarović E, Jonjić N.

Pathol Res Pract. 2014 May;210(5):279-84. doi: 10.1016/j.prp.2014.01.003. Epub 2014 Jan 31.

PMID:
24553301
18.

Desmocollin 2 is a new immunohistochemical marker indicative of squamous differentiation in urothelial carcinoma.

Hayashi T, Sentani K, Oue N, Anami K, Sakamoto N, Ohara S, Teishima J, Noguchi T, Nakayama H, Taniyama K, Matsubara A, Yasui W.

Histopathology. 2011 Oct;59(4):710-21. doi: 10.1111/j.1365-2559.2011.03988.x.

PMID:
22014052
19.

Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.

Chuang AY, DeMarzo AM, Veltri RW, Sharma RB, Bieberich CJ, Epstein JI.

Am J Surg Pathol. 2007 Aug;31(8):1246-55.

PMID:
17667550
20.

Uroplakin II (UPII), GATA3, and p40 are Highly Sensitive Markers for the Differential Diagnosis of Invasive Urothelial Carcinoma.

Hoang LL, Tacha D, Bremer RE, Haas TS, Cheng L.

Appl Immunohistochem Mol Morphol. 2015 Jan 21. [Epub ahead of print]

PMID:
25611245
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk